Viatris VTRS
NASDAQ VTRS
$17.60 +0.14 (+0.80%)
At close: Oct 2, 2026 · 4:00 PM EDT

Viatris (VTRS) Liabilities from Discontinued Operations (2022 - 2024)

Updated

Viatris (VTRS) reported Liabilities from Discontinued Operations of $32.8 million for Q2 2024, down 86.0% from the prior quarter.

Analysis

Viatris (VTRS) Liabilities from Discontinued Operations (2022 - 2024) Analysis & Trends

At the end of FY2023, Viatris posted Liabilities from Discontinued Operations of $275.1 million.

  • Five-year quarterly Liabilities from Discontinued Operations spans a low of $14.3 million in Q3 2023 and a high of $335.3 million in Q3 2022.
  • Per Business Quant data, the three quarters before Q2 2024 came in at $234.8 million (Q1 2024), $275.1 million (Q4 2023) and $14.3 million (Q3 2023).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,082.65 Bn 1,051.23 Bn 19.71 Bn
2 Johnson & Johnson 623.68 Bn 542.21 Bn 17.26 Bn
3 AbbVie 459.43 Bn 432.59 Bn 12.70 Bn
4 Merck 354.80 Bn 309.23 Bn 12.21 Bn
5 Novartis Ag 269.16 Bn 225.03 Bn 11.24 Bn
6 Astrazeneca 244.40 Bn 217.97 Bn 12.86 Bn
7 Amgen 220.17 Bn 175.57 Bn 7.24 Bn
8 Gilead Sciences 183.05 Bn 157.16 Bn 6.22 Bn
9 Pfizer 160.27 Bn 107.22 Bn 10.94 Bn
10 Viatris 20.05 Bn 15.07 Bn 1.46 Bn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2024 32.80 Mn
Mar 31, 2024 234.80 Mn
Dec 31, 2023 275.10 Mn
Sep 30, 2023 14.30 Mn
Sep 30, 2022 335.30 Mn
Jun 30, 2022 285.10 Mn
Mar 31, 2022 277.70 Mn
API Access

Viatris Liabilities from Discontinued Operations API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=liabilities-from-discontinued-operations&ticker=VTRS&period=max&api_key=YOUR_API_KEY